Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Change in Inventory (2023 - 2025)

Tg Therapeutics (TGTX) has 3 years of Change in Inventory data on record, last reported at -$563000.0 in Q4 2025.

  • For Q4 2025, Change in Inventory fell 102.27% year-over-year to -$563000.0; the TTM value through Dec 2025 reached $33.5 million, down 49.96%, while the annual FY2025 figure was $33.5 million, 49.96% down from the prior year.
  • Change in Inventory reached -$563000.0 in Q4 2025 per TGTX's latest filing, up from -$8.7 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $46.3 million in Q1 2025 and bottomed at -$8.7 million in Q3 2025.
  • Average Change in Inventory over 3 years is $11.4 million, with a median of $2.6 million recorded in 2024.
  • Peak YoY movement for Change in Inventory: surged 350.78% in 2024, then crashed 442.32% in 2025.
  • A 3-year view of Change in Inventory shows it stood at $5.5 million in 2023, then soared by 350.78% to $24.8 million in 2024, then plummeted by 102.27% to -$563000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$563000.0 in Q4 2025, -$8.7 million in Q3 2025, and -$3.6 million in Q2 2025.